HomeNewsScreenerChartsMapsGroupsPortfolioInsiderFuturesForexCryptoCalendarPricing
Theme 		Help

NRXS

Neuraxis Inc

Last Close
May 15  •  04:00PM ET
7.87
Dollar change
-0.48
Percentage change
-5.75 %
Healthcare • Biotechnology • USA • Micro • AMEX
Peers: NMTC NRXP BIVI IMUX ALZN
Scroll to Statements
Index
-
P/E
-
EPS (ttm)
-0.81
Insider Own
28.00%
Shs Outstand
11.45M
Perf Week
-4.02%
Market Cap
97.47M
Forward P/E
-
EPS next Y
-0.06
Insider Trans
12.40%
Shs Float
8.92M
Perf Month
6.93%
Enterprise Value
90.74M
PEG
-
EPS next Q
-0.17
Inst Own
19.64%
Short Float
4.41%
Perf Quarter
60.29%
Income
-8.07M
P/S
22.77
EPS this Y
37.89%
Inst Trans
-7.47%
Short Ratio
2.03
Perf Half Y
202.69%
Sales
4.28M
P/B
15.69
EPS next Y
89.83%
ROA
-123.70%
Short Interest
0.39M
Perf YTD
73.35%
Book/sh
0.50
P/C
13.77
EPS next 5Y
-
ROE
-242.53%
52W High
9.33 -15.65%
Perf Year
233.47%
Cash/sh
0.57
P/FCF
-
EPS past 3/5Y
-1.64% -6.18%
ROIC
-122.79%
52W Low
2.07 280.19%
Perf 3Y
-
Dividend Est.
-
EV/EBITDA
-
Sales past 3/5Y
9.96% 13.08%
Gross Margin
85.00%
Volatility
9.86% 8.77%
Perf 5Y
-
Dividend TTM
-
EV/Sales
21.20
EPS Y/Y TTM
34.17%
Oper. Margin
-169.93%
ATR (14)
0.69
Perf 10Y
-
Dividend Ex-Date
-
Quick Ratio
2.81
Sales Y/Y TTM
45.88%
Profit Margin
-188.57%
RSI (14)
50.89
Recom
1.00
Dividend Gr. 3/5Y
- -
Current Ratio
2.89
EPS Q/Q
46.63%
SMA20
-1.11%
Beta
1.51
Target Price
11.00
Payout
-
Debt/Eq
0.06
Sales Q/Q
79.52%
SMA50
6.74%
Rel Volume
0.58
Prev Close
8.35
Employees
24
LT Debt/Eq
0.03
Earnings
May 12 BMO
SMA200
79.04%
Avg Volume
193.84K
Price
7.87
IPO
Aug 09, 2023
Option/Short
No / Yes
EPS/Sales Surpr.
5.26% 10.89%
Trades
Volume
113,272
Change
-5.75%
May-12-26 07:01PM
Neuraxis Inc (NRXS) Q1 2026 Earnings Call Highlights: Strong Revenue Growth Amid Coverage Challenges
(GuruFocus.com)
07:05AM
NeurAxis Reports Record First Quarter 2026 Financial Results Driven by 80% Year Over Year Revenue Growth
(GlobeNewswire)
May-11-26 09:23AM
Earnings To Watch: Neuraxis Inc (NRXS) Reports Q1 2026 Result
(GuruFocus.com)
May-05-26 07:00AM
NeurAxis to Host First Quarter 2026 Results and Business Update Call on Tuesday, May 12, 2026
(GlobeNewswire)
Apr-22-26 07:00AM
NeurAxis Expands Payer Coverage with Four New Medical Policies
(GlobeNewswire)
07:00AM Loading…
Apr-10-26 07:00AM
NeurAxis, Inc. Announces Preferred Stock Dividend
(GlobeNewswire) -5.66%
Mar-19-26 03:02PM
Neuraxis Inc (NRXS) Q4 2025 Earnings Call Highlights: Revenue Growth Amidst Operational Challenges
(GuruFocus.com)
08:30AM
NeurAxis, Inc. Q4 2025 Earnings Call Summary
(Moby)
07:05AM
NeurAxis Reports Strong Fourth Quarter and Full Year 2025 Financial Results
(GlobeNewswire)
Mar-12-26 09:00AM
NeurAxis to Host Fourth Quarter and Full Year 2025 Results and Business Update Call on Thursday, March 19, 2026
(GlobeNewswire)
Jan-08-26 08:00AM
NeurAxis Achieves Major Milestone with AMA Category I CPT Code Now in Effect, Establishing a Permanent Reimbursement Pathway
(GlobeNewswire)
Jan-06-26 04:41AM
The Zacks Analyst Blog Meta, Bank of America, The Procter & Gamble, Espey and NeurAxis
(Zacks)
Jan-05-26 04:34PM
Top Stock Reports for Meta, Bank of America & Procter & Gamble
(Zacks)
Dec-19-25 08:00AM
NeurAxis Achieves Medical Coverage Policy Milestone, Expanding Access to Approximately 45 million additional Covered Lives
(GlobeNewswire) +11.81%
Dec-01-25 07:00AM
NeurAxis Secures Veterans Affairs Federal Supply Schedule Contract, Broadening Access to More Patients with Functional Abdominal Pain
(GlobeNewswire)
12:17PM Loading…
Nov-17-25 12:17PM
NRXS Stock Declines Post Q3 Earnings Despite Continued Revenue Growth
(Zacks)
Nov-12-25 08:00AM
NeurAxis Announces New Medical Policy Coverage in Michigan, Adding 566,000 Covered Lives
(GlobeNewswire) +7.88%
Nov-11-25 07:00AM
NeurAxis Reports Strong Third Quarter 2025 Financial Results Driven by a 22% Growth in Revenues
(GlobeNewswire) -5.86%
Nov-04-25 08:30AM
NeurAxis to Host Third Quarter 2025 Results and Business Update Call on Tuesday, November 11, 2025
(GlobeNewswire) -5.22%
Oct-24-25 08:00AM
NeurAxis Awarded First Ever FDA Clearance for the Treatment of Pain in Functional Dyspepsia (FD) with associated Nausea Symptoms in the Adult Patient Population
(GlobeNewswire) -8.64%
Sep-18-25 08:00AM
NeurAxis to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025
(GlobeNewswire)
Sep-17-25 05:53AM
The Zacks Analyst Blog Highlights Alphabet, IBM, Merck, SandRidge Energy and NeurAxis
(Zacks) +5.35%
Sep-16-25 04:42PM
Top Research Reports for Alphabet, IBM & Merck
(Zacks)
Aug-18-25 02:27PM
NeurAxis Stock Down Following Q2 Earnings Despite Revenue Growth
(Zacks)
Aug-12-25 07:00AM
NeurAxis Reports Strong Second Quarter 2025 Financial Results Driven by a 46% Growth in Revenues
(GlobeNewswire)
Aug-05-25 08:30AM
NeurAxis to Host Second Quarter 2025 Results and Business Update Call on Tuesday, August 12, 2025
(GlobeNewswire)
Jun-27-25 04:53AM
The Zacks Analyst Blog Highlights Microsoft, NVIDIA, Bank of America, BK Technologies and NeurAxis
(Zacks)
Jun-26-25 04:34PM
Top Stock Reports for Microsoft, NVIDIA & Bank of America
(Zacks)
Jun-17-25 08:00AM
NeurAxis Announces New Medical Policy Coverage with Two Health Insurers, Adding 700,000 Covered Lives
(GlobeNewswire)
Jun-10-25 08:00AM
NeurAxis Achieves Critical Milestone; Secures Key Academic Society Guidelines Recommendation for Treatment of Functional Abdominal Pain (FAP) in IBS
(GlobeNewswire) -8.65%
08:00AM Loading…
May-27-25 08:00AM
NeurAxis to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025
(GlobeNewswire)
May-22-25 01:03PM
NeurAxis Announces Closing of $5.0 Million Registered Direct Offering
(GlobeNewswire) -5.31%
May-21-25 07:00AM
NeurAxis Announces $5.0 Million Registered Direct Offering
(GlobeNewswire) -19.80%
May-20-25 08:00AM
NeurAxis Awarded First Ever FDA Clearance for the Treatment of Pediatric FAP/Functional Dyspepsia (FD) and Associated Nausea Symptoms
(GlobeNewswire) +75.77%
May-15-25 12:06PM
NeurAxis Stock Gains Following Strong Q1 Earnings and FDA Milestones
(Zacks)
May-12-25 08:15AM
NeurAxis Reports Strong First Quarter 2025 Financial Results Driven by a 39% Growth in Revenues
(GlobeNewswire) +16.00%
May-05-25 09:00AM
NeurAxis to Host First Quarter 2025 Results and Business Update Call on Monday, May 12, 2025
(GlobeNewswire) -11.64%
May-01-25 04:49AM
The Zacks Analyst Blog Highlights Amazon, Johnson & Johnson, Cisco Systems and NeurAxis
(Zacks)
Apr-30-25 05:02PM
Top Stock Reports for Amazon.com, Johnson & Johnson & Cisco Systems
(Zacks) +5.86%
Apr-15-25 09:00AM
NeurAxis to Present at the Planet MicroCap Showcase: VEGAS in partnership with MicroCapClub on Wednesday, April 23, 2025 & 1x1 Meetings on Thursday, April 24, 2025
(GlobeNewswire)
Mar-24-25 11:20AM
NeurAxis Stock Gains Post Q4 Earnings and Revenue Growth
(Zacks) -6.06%
Mar-20-25 04:18PM
NeurAxis, Inc. (NRXS) Q4 2024 Earnings Call Transcript
(SeekingAlpha)
08:15AM
NeurAxis Reports Strong Fourth Quarter 2024 Financial Results Driven by a 43% Increase in Revenues
(GlobeNewswire)
Mar-12-25 09:00AM
NeurAxis to Host Fourth Quarter and Full Year 2024 Results and Business Update Call on Thursday, March 20, 2025
(GlobeNewswire)
Jan-21-25 01:45PM
UPDATE - NeurAxis Announces New Medical Policy Coverage with a Prominent Insurer for Over Five Million Lives Across Multiple States
(GlobeNewswire)
09:00AM
NeurAxis Announces New Medical Policy Coverage with Molina Healthcare for Over Five Million Lives Across Multiple States
(GlobeNewswire)
Jan-13-25 09:00AM
NeurAxis Inc. Issues Letter to Shareholders
(GlobeNewswire)
Jan-08-25 09:00AM
NeurAxis Inc. Announces Strong Preliminary Unaudited Fourth Quarter 2024 Results; Revenues Increased 50% Year-Over-Year
(GlobeNewswire)
Jan-06-25 09:00AM
NeurAxis Inc. to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025
(GlobeNewswire) +11.57%
Dec-10-24 09:00AM
NeurAxis Inc. Announces FDA 510(k) Clearance of RED for Testing and Evaluation of Patients with Chronic Constipation
(GlobeNewswire) -7.48%
Nov-12-24 08:10AM
NeurAxis Reports Strong Third Quarter 2024 Financial Results Driven by a 40% Increase in Revenues
(GlobeNewswire) +26.40%
Nov-05-24 09:00AM
NeurAxis to Host Third Quarter 2024 Results and Business Update Call on Tuesday, November 12, 2024
(GlobeNewswire)
Nov-04-24 09:00AM
NeurAxis Receives New FDA 510(K) Clearance for IB-Stim, Expanding its Addressable Market
(GlobeNewswire)
Oct-29-24 09:00AM
NeurAxis Announces Capital Blue Cross Medical Policy Coverage for PENFS, effective October 1st 2024
(GlobeNewswire)
Oct-22-24 09:00AM
NeurAxis Announces New CPT Category I Code for Percutaneous Electrical Nerve Field Stimulation
(GlobeNewswire) +5.07%
Sep-19-24 09:00AM
NeurAxis to Participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024
(GlobeNewswire)
Aug-27-24 09:00AM
NeurAxis Announces Geisinger Health Plan Medical Policy Coverage for PENFS, Effective September 15 2024
(GlobeNewswire)
Aug-13-24 09:00AM
NeurAxis Announces BCBS of Vermont Medical Policy Coverage for PENFS, effective October 1st 2024
(GlobeNewswire)
Aug-09-24 08:00AM
NeurAxis Reports Second Quarter 2024 Financial Results
(GlobeNewswire) +9.12%
Aug-05-24 09:00AM
NeurAxis to Host Second Quarter 2024 Results and Business Update Call on Friday, August 9, 2024
(GlobeNewswire) -17.61%
Jun-07-24 09:00AM
NeurAxis Announces New Submission to the FDA for the Expansion of its IB-Stim Label; Provides Compliance with NYSE Guidelines on Audit Disclosure
(GlobeNewswire)
May-22-24 08:00AM
NeurAxis Reports First Quarter 2024 Financial Results
(GlobeNewswire)
May-21-24 09:00AM
NeurAxis to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024
(GlobeNewswire)
May-16-24 09:00AM
NeurAxis Announces New Medical Policy Coverage For Nearly Six Million Lives in Florida
(GlobeNewswire) +11.96%
May-15-24 04:30PM
NeurAxis to Host First Quarter 2024 Results and Business Update Call on Wednesday, May 22, 2024
(GlobeNewswire)
Apr-23-24 09:00AM
NeurAxis Announces New Medical Policy Coverage in North Dakota
(GlobeNewswire) -11.18%
Apr-12-24 08:44AM
NeurAxis, Inc. (NASDAQ:NRXS) Q4 2023 Earnings Call Transcript
(Insider Monkey)
Apr-09-24 04:05PM
NeurAxis Reports Fourth Quarter and Fiscal Year 2023 Financial Results
(GlobeNewswire)
Apr-01-24 04:15PM
NeurAxis to Host Fourth Quarter and Full Year 2023 Results and Business Update Call on Tuesday, April 9, 2024
(GlobeNewswire)
Mar-27-24 09:00AM
NeurAxis Announces IB-Stim Results from a Large, Pediatric, Multi-Center Registry
(GlobeNewswire)
Mar-11-24 09:00AM
NeurAxis Announces Highmark BCBS Policy Coverage
(GlobeNewswire)
Mar-04-24 09:00AM
NeurAxis Announces Blue Cross and Blue Shield of Kansas City Policy Coverage
(GlobeNewswire) +8.82%
Feb-27-24 11:00AM
NeurAxis to Present at Oppenheimer 34th Annual Healthcare MedTech & Services Conference
(GlobeNewswire)
Jan-31-24 09:00AM
NeurAxis Appoints Timothy Henrichs as Chief Financial Officer
(GlobeNewswire)
Dec-20-23 09:00AM
NeurAxis, Inc. Issues Letter to Shareholders from Brian Carrico, President and Chief Executive Officer
(GlobeNewswire)
Nov-20-23 05:30PM
NeurAxis Reports Third Quarter 2023 Financial Results
(GlobeNewswire)
Nov-15-23 09:00AM
NeurAxis Announces CareFirst BCBS Policy Coverage
(GlobeNewswire) +14.17%
Nov-14-23 09:00AM
NeurAxis Secures $3 Million Financing
(GlobeNewswire)
Nov-08-23 09:00AM
NeurAxis Signs Exclusive Option Agreement with University of Michigan for Innovative Gastrointestinal Device
(GlobeNewswire)
Sep-26-23 09:00AM
NeurAxis Announces Results of Comparative Study of IB-Stim and Standard Medical Therapy in Adolescents with Functional Abdominal Pain Disorders
(GlobeNewswire)
Sep-21-23 08:00AM
NeurAxis Reports Second Quarter 2023 Financial Results
(GlobeNewswire)
Sep-13-23 09:00AM
NeurAxis to Present at the Gilmartin Group Emerging Growth Showcase
(GlobeNewswire) +7.87%
Sep-12-23 10:15AM
EXCLUSIVE: NeurAxis' Nerve Field Stimulation Tech Shows Improved Quality of Life of Adolescents Patients With Irritable Bowel Syndrome
(Benzinga) -16.92%
09:00AM
NeurAxis Announces Publication of Prospective Study Showing IB-Stim Improves Quality of Life of Adolescents with IBS
(GlobeNewswire)
Aug-29-23 09:00AM
NeurAxis Highlights Pediatric Post-Concussion Clinical Study
(GlobeNewswire)
Aug-24-23 09:00AM
NeurAxis Highlights Strength of its Board of Directors
(GlobeNewswire) -10.15%
Aug-22-23 09:00AM
NeurAxis Highlights Two Independent Studies Showing Benefits of IB-Stim in Adolescents Involving the Gut Microbiome
(GlobeNewswire) +16.50%
Aug-17-23 09:02AM
NeurAxis Announces Over $8 Million in IB-Stim Revenue
(GlobeNewswire)
Aug-15-23 09:00AM
NeurAxis Announces Positive University of Michigan IB-Stim Cost Effectiveness Study at ANMS 2023
(GlobeNewswire)
Aug-11-23 09:30AM
Goldman Small Cap Research Publishes New Research Report on NeurAxis, Inc.
(ACCESSWIRE)
Aug-10-23 09:00AM
NeurAxis Highlights Current Commercial Insurance Coverage with BCBS Massachusetts, BCBS South Carolina, BCBS Nebraska, and Quartz Wisconsin
(GlobeNewswire)
09:00AM
Exchange Listing Client, Neuraxis, Inc., Successfully Completes Its Initial Public Offering and NYSE Listing
(GlobeNewswire)
Aug-09-23 10:00AM
NeurAxis Announces Pricing of Initial Public Offering
(GlobeNewswire)
NeurAxis, Inc. engages in the provision of neuromodulation therapies to address chronic and debilitating conditions in children. Its product, IB-Stim, is a non-surgical device that works by sending gentle electrical impulses into cranial nerve bundles located in the ear. The company was founded by Gary Peterson and Christopher Robin Brown in 2011 and is headquartered in Carmel, IN.
PresidentMr. Brian Carrico
Chief Financial OfficerMr. Timothy Robert Henrichs
Senior VP of Science & Technology and Chief Medical OfficerDr. Adrian Miranda
Chief Regulatory Officer and Compliance & Privacy OfficerDr. Thomas Carrico
FounderDr. Christopher Robin Brown D.D.S.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Henrichs Timothy RobertChief Financial OfficerApr 01 '26Buy1.967,59314,8827,593Apr 03 11:23 AM
Carrico Thomas JoesephCRO, CCO, CPOApr 01 '26Buy1.966671,307331,903Apr 03 11:21 AM
Carrico Brian AllenChief Executive OfficerApr 01 '26Buy1.968,06015,798348,178Apr 03 11:19 AM
Hannasch Brian10% OwnerFeb 12 '26Buy4.9240,000196,8001,211,522Feb 13 04:04 PM
Hannasch Brian10% OwnerFeb 11 '26Buy4.6540,000186,0001,171,522Feb 13 04:04 PM
Aharon GilDirectorDec 23 '25Buy3.52286,1381,007,206286,138Dec 29 05:12 PM
MASIMO CORP10% OwnerJul 01 '25Sale2.25821,3271,847,9860Jul 03 05:38 PM
Hannasch Brian10% OwnerJul 01 '25Buy2.25355,556800,0011,131,522Jul 03 11:24 AM
open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR
Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)